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Abstract
Next-generation sequencing has been used to infer the clonality of heterogeneous tumor samples. These analyses yield
specific predictions—the population frequency of individual clones, their genetic composition, and their evolutionary
relationships—which we set out to test by sequencing individual cells from three subjects diagnosed with secondary acute
myeloid leukemia, each of whom had been previously characterized by whole genome sequencing of unfractionated tumor
samples. Single-cell mutation profiling strongly supported the clonal architecture implied by the analysis of bulk material. In
addition, it resolved the clonal assignment of single nucleotide variants that had been initially ambiguous and identified
areas of previously unappreciated complexity. Accordingly, we find that many of the key assumptions underlying the
analysis of tumor clonality by deep sequencing of unfractionated material are valid. Furthermore, we illustrate a single-cell
sequencing strategy for interrogating the clonal relationships among known variants that is cost-effective, scalable, and
adaptable to the analysis of both hematopoietic and solid tumors, or any heterogeneous population of cells.
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Introduction
Intratumoral heterogeneity is an emerging hallmark of cancer
that can be interrogated genome-wide with next-generation
sequencing. Critically, sub-populations of tumor cells are orga-
nized into hierarchies through clonal evolution. A powerful
strategy for studying this population structure is multi-sam-
pling—independently assaying genetic variation at distinct points
in time or space and comparing mutation profiles. In particular,
whole genome sequencing (WGS) of de novo acute myeloid
leukemia (AML) has demonstrated genetic evolution between
diagnosis and relapse [1,2], and similar results have been obtained
from WGS of paired primary-metastasis samples in breast cancer
[3]. Furthermore, whole exome sequencing (WES) of multiple
regions within primary tumors has revealed extensive regional
heterogeneity in pancreatic [4], hepatocellular [5], and renal [6]
carcinomas. Thus, clonal heterogeneity within tumors compounds
the biological complexity of human cancers, and a detailed
understanding of this is important for clinical genomics.
The ultimate resolution of multi-sampling is single-cell analysis,
which is rapidly becoming tractable. For example, Anderson et al.
have used fluorescence in situ hybridization (FISH) to genotype up
to five so-called ‘‘driver’’ lesions in individual pediatric acute
lymphoblastic leukemia (ALL) cells, which demonstrated a range
of clonal architectures (from linear to complex) in different subjects
[7]. Jan et al., Potter et al., and Klco et al. have reported similar
findings using either single-cell allele-specific PCR or amplicon
sequencing to assay five to ten clonal markers in de novo AML or
pediatric ALL [8–10]. In broader (genome-wide) analyses, Navin
et al. and Voet et al. have leveraged WGS to call copy number
variants (CNVs) in single cells, which they used to reconstruct the
phylogenetic history of breast cancer cell lines and primary tumors
[11,12].
In addition to multi-sampling strategies, we and others have
reported clonal inference from deep sequencing of individual
tumor samples [1,13–15]. Briefly, this approach uses the fraction
of sequencing reads calling a specific somatic mutation (i.e., the
variant allele fraction, or VAF) to estimate the frequency of that
variant in the original sample. Often, large numbers of single
nucleotide variants (SNVs) cluster at a common VAF, suggesting
the presence of a clonal population at a defined frequency.
Analyzing tumors in this way yields specific predictions about the
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clonal relationships among variants detected in unfractionated
samples: 1) the genetic composition of individual clones (groups of
SNVs that arose together), 2) the frequency of each clone
(proportional to the mean VAF of the corresponding cluster),
and 3) a model for how the clonal architecture evolved (clones at
lower frequencies descending from those at higher frequencies).
We set out to test these predictions by sequencing single cells
from three subjects with an initial diagnosis of myelodysplastic
syndrome (MDS), each of whom progressed to secondary AML
(sAML). We had previously characterized these subjects by WGS
of both MDS and sAML bone marrow as well as matched skin
samples, resulting in a call set of several thousand validated
somatic mutations in addition to specific models for the clonal
architecture of each tumor [14]. In the current study, we used
targeted sequencing to genotype .1,900 of these positions in a
dozen single cells from each subject. We used SNP array data to
quantify the accuracy of single-cell variant calling, and—as
reported by others—we observed frequent genotyping errors due
to stochastic biases in whole genome amplification (allelic dropout,
or ADO) [11,12,16]. Nevertheless, while ADO inflated our false
negative rate, we maintained a relatively low false positive rate. It
was therefore possible to evaluate the major clonal relationships
among targeted variants using single-cell sequencing.
Ultimately, the single-cell data strongly supported the major
clonal populations predicted from the analysis of bulk tissue, in
addition to resolving the clonality of SNVs that were originally
ambiguous and suggesting previously unappreciated complexity
among rare subclones. Accordingly, our findings validate many of
the critical assumptions underlying the inference of tumor clonality
from unfractionated samples, in addition to demonstrating a high-
throughput approach to single-cell genotyping that provides
insight into the clonal architecture of heterogeneous samples.
Results
Targeted Sequencing of Single-Cell, Two-Cell, and
Unfractionated Samples
We prepared a total of 56 sequencing libraries from whole
genome amplified (WGA) single-cell and two-cell sAML samples
in addition to non-WGA unfractionated MDS, sAML, and normal
(skin) samples (Table S1). We used hybridization capture to
enrich these libraries for 1,953 somatic SNVs discovered and
validated previously in unfractionated samples [14] (Table S2).
Sequencing yielded 4.1 Gb of de-duplicated data that aligned to
targeted loci, resulting in an average depth of coverage of 1486
per sample (Table 1, Table S3). The subject identity
corresponding to each sequencing library was confirmed using
variant calls at both germline SNPs and targeted somatic SNVs
(Table S4, Table S5). In order to assess the quality of our
capture reagent, we compared the VAF distributions of variants in
unfractionated MDS and sAML samples to those previously
reported [14] (Figure S1), finding a strong correlation between
these independently-generated datasets (R2 = 0.66–0.96).
Consistent with previous reports, we observed a number of
differences in sequencing performance between WGA libraries
and those prepared from unfractionated material [11,12,16]. In
particular, single- and two-cell libraries had a lower proportion of
the capture target covered at any threshold (Figure 1A). This was
attributable in part to 20% fewer reads obtained from libraries
prepared from WGA material (Table 1). Furthermore, these
libraries had a lower on-target rate (likely driven by locus dropout)
and a higher rate of PCR duplicates (i.e., reduced library
complexity) (Table 1). In addition, single- and two-cell samples
had a significantly less uniform distribution of reads across the
capture target (Figure 1B), again reflecting WGA biases. In
aggregate, these technical issues limited callable positions (sites
with $256 coverage) to approximately 55% of targeted SNVs in
single- and two-cell samples (41%–63% for single-cell and 46–53%
for two-cell libraries).
Performance of Variant Calling
To quantify the accuracy of variant calling in single cells, we
examined germline (i.e., inherited) SNPs genotyped previously
using Affymetrix 6.0 arrays. We evaluated three separate variant
callers: SAMtools [17], VarScan2 [18], and the Genome Analysis
Author Summary
Human cancers are genetically diverse populations of cells
that evolve over the course of their natural history or in
response to the selective pressure of therapy. In theory, it
is possible to infer how this variation is structured into
related populations of cells based on the frequency of
individual mutations in bulk samples, but the accuracy of
these models has not been evaluated across a large
number of variants in individual cells. Here, we report a
strategy for analyzing hundreds of variants within a single
cell, and we apply this method to assess models of tumor
clonality derived from bulk samples in three cases of
leukemia. The data largely support the predicted popula-
tion structure, though they suggest specific refinements.
This type of approach not only illustrates the biological
complexity of human cancer, but it also has the potential
to inform patient management. That is, precise knowledge
of which variants are present in which populations of cells
may allow physicians to more effectively target combina-
tions of mutations and predict how patients will respond
to therapy.
Table 1. Sequencing metrics.
Total (Mb) Aligned (Mb) Aligned (%) On-Target (%) Duplicate (%)
On-Target, Unique
Coverage (X)
Sample Average (n =56) 408 397 97.3 25.6 29.0 148
Unsorted Sample
Average (n=14)
490 487 99.5 35.7 24.0 261
Single-Cell Sample
Average (n=36)
382 369 96.6 22.4 30.3 113
Two-Cell Sample
Average (n=6)
373 358 96.2 21.0 33.1 94
doi:10.1371/journal.pgen.1004462.t001
Leukemia Single-Cell Sequencing
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Toolkit (GATK) Unified Genotyper [19,20]. With SAMtools and
VarScan2, we called variants from individual samples, whereas
with GATK, we called variants jointly across all single-cell
libraries. At homozygous SNPs, all three callers performed
similarly (Figure 2A, 2B). However, at heterozygous SNPs
(which best approximate targeted SNVs), calling samples jointly
yielded a modest benefit in sensitivity, while reducing specificity
(Figure 2C). Based on these results, we chose to call variants
jointly using GATK at sites with $256 coverage, and we
estimated our sensitivity and specificity for singe-cell variant
calling to be 0.88 and 0.98, respectively. As a caveat, benchmark-
ing joint variant calling at germline SNPs (which are present in
every cell) potentially overestimates sensitivity to detect subclonal
SNVs (which may be present in only a subset of cells).
Nevertheless, joint variant calling likely offers a genuine increase
in sensitivity, without incurring much cost in specificity, especially
when calls are restricted to sites with high coverage.
As shown in Table 2, the majority of genotyping errors
(assessed at germline SNPs) were false negatives, i.e. failures to
detect true non-reference alleles, which resulted in reduced true
positive rates (TPRs). These occurred exclusively at heterozygous
positions in libraries prepared from WGA material, implicating
ADO as the underlying mechanism (approximately equal to the
false negative rate, or FNR). This assumption is further supported
by the observation that the frequency of homozygous reference
calls was similar to that of homozygous variant calls at known
heterozygous SNPs (Figure S2). ADO is a well-documented
limitation of commercial single-cell WGA kits [11,12,16]. Never-
theless, although our analysis of germline SNPs demonstrated that
single-cell reference allele calls were enriched for false negatives (at
heterozygous positions), it also showed that non-reference allele
calls were generally accurate (overall false positive rate, or FPR,
approximately equal to 0.02). This asymmetry between FNR and
FPR was critical for differentiating genuine clonal relationships
among targeted SNVs from genotyping errors.
Finally, we tested whether ADO could be linked to systematic
(i.e., locus-specific) effects, or if it was predominantly stochastic. To
do this, we compared the rate at which inherited heterozygous
SNPs common to all three subjects were called reference in single-
cell libraries (Figure S3). In general, the dropout rate of a specific
locus across single-cell libraries from one subject was not predictive
of its dropout rate across single-cell libraries in another (R2 = 0.25–
0.30), suggesting that ADO was not attributable to strong
positional biases.
Validation of Sample Cellularity
As an additional quality control measure, we asked if the VAF
distribution in single cells could be used to infer sample cellularity.
In single cells, the true (unobserved) VAF of heterozygous variants
is 0.5 (at diploid loci). As shown in Figure S4, S5, S6, the VAF
distributions in single-cell samples exhibited high variance (ranging
from 0 to 1) compared to unsorted samples, reflecting stochastic
biases in WGA. However, the mean VAF for each cluster, as well
as for germline heterozygous SNPs, was fixed at approximately
Figure 1. Depth and distribution of coverage for each sequencing library (n=56). (A) Cumulative coverage represented as the proportion of
the capture target (y-axis) with read depth greater than or equal to specific coverage thresholds (x-axis). Coverage values are derived from quality-
filtered data (de-duplicated, phred-scaled alignment quality$10, phred- scaled base quality$13). The intersection of each curve with y= 0.5 identifies
the median coverage. Higher coverage was obtained for the unsorted samples (median 2286), compared to the single- or two-cell samples (median
286). (B) Lorenz curve detailing uniformity of coverage as proportion of targeted bases versus proportion of sequenced bases. Dashed line (y = x)
represents a perfectly uniform distribution of read depth across the capture target. Libraries prepared from WGA samples (single- and two-cells) exhibit
significantly less uniform representation, compared to libraries derived from unfractionated material. See Table 1 and Table S3 for additional details.
doi:10.1371/journal.pgen.1004462.g001
Leukemia Single-Cell Sequencing
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0.5. In contrast, in intentionally ‘‘cross-contaminated’’ two-cell
samples, the mean VAF of individual clusters (but never germline
heterozygotes) dropped to 0.25, the precise dilution expected from
the admixture of two cells sharing some, but not all, heterozygous
SNVs (Figure S4, Figure S6). To analyze this further, we
modeled these distributions computationally and used maximum
likelihood analysis integrating a site-specific error model to assess
the probability that each dataset was generated from all possible
combinations of two cells. This predicted that .90% of single-cell
libraries were derived from true single-cell samples (Table S7).
Assessment of Tumor Clonality
Previously, we generated WGS data from MDS, sAML and
normal samples for each subject in the current study, and we
analyzed the VAF distribution of validated somatic mutations to
infer the clonal architecture of each tumor [14]. In the current
Figure 2. Performance of variant calling. The specificity (A) and sensitivity (B, C) of three separate variant callers—SAMtools, VarScan2, and
GATK—were evaluated by analyzing single-cell variant calls at germline SNPs previously ascertained by Affymetrix SNP arrays [14]. As we have
defined true positive and true negative, sensitivity is undefined at homozygous reference positions (there are no true positives) and specificity is
undefined at heterozygous and homozygous variant positions (there are no true negatives). Sensitivity and specificity were similar among all three
callers at homozygous positions, but GATK demonstrated greater sensitivity at heterozygous sites. Variants were called jointly across all single-cell
libraries with the GATK Unified Genotyper utility, whereas variants were called independently for each sample using SAMtools and VarScan2. See
Table 2 and Table S6 for additional details. TPR: true positive rate. FPR: false positive rate.
doi:10.1371/journal.pgen.1004462.g002
Table 2. Performance of variant calling at germline SNPs.
# of Positions TPR FPR FNR
Homozygous Sites Heterozygous Sites
UPN461282 Average: Unsorted Cells 17 1.00 0.00 0.00 0.00
Average: Single Cells 9 0.90 0.00 0.00 0.21
Average: Two Cells 8 0.88 0.00 0.00 0.25
UPN182896 Average: Unsorted Cells 329 0.99 0.00 0.00 0.00
Average: Single Cells 189 0.93 0.01 0.00 0.13
Average: Two Cells 181 0.94 0.01 0.00 0.09
UPN288033 Average: Unsorted Cells 327 1.00 0.01 0.00 0.00
Average: Single Cells 195 0.92 0.02 0.00 0.13
Average: Two Cells 204 0.98 0.03 0.00 0.04
True Positive (TP): $1 non-reference allele called by Affymetrix array, $1 non-reference allele called by sequencing.
True Negative (TN): 0 non-reference alleles called by Affymetrix array, 0 non-reference alleles called by sequencing.
False Positive (FP): 0 non-reference alleles called by Affymetrix array, $1 non-reference allele called by sequencing.
False Negative (FN): $1 non-reference allele called by Affymetrix array, $0 non-reference alleles called by sequencing.
True Positive Rate (TPR): TP/(TP+FN) = sensitivity = power.
False Positive Rate (FPR): FP/(FP+TN) = 1-specificity.
False Negative Rate (FNR): FN/(TP+FN) = 1 - sensitivity = type II error.
doi:10.1371/journal.pgen.1004462.t002
Leukemia Single-Cell Sequencing
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study, we applied SciClone—a variational Bayesian algorithm—to
the original WGS data to refine these models [13,21]. As shown in
Figure 3A–C, groups of SNVs cluster at distinct frequencies, and
we hypothesized that each cluster represented a clonal population
of tumor cells. I.e., clustered SNVs were predicted to colocalize
within individual cells. Furthermore, we predicted that the
population frequency of putative clones was proportional to the
mean VAF of the corresponding cluster. Finally, we hypothesized
that clones present at successively lower frequencies evolved
linearly from clones at higher frequencies, i.e., that these
populations were nested. Accordingly, subjects were predicted to
be monoclonal (UPN182896) or biclonal (UPN461282,
UPN288033) at the time of MDS diagnosis, and harbor two or
more clones upon progression to sAML (Figure 3D). In addition,
our analysis of both unfractionated blood and bone marrow
samples indicated that tumor clonality was similar in both
compartments (consistent with recent findings in both de novo
AML and MDS [10,22]), though UPN288033 had an overall
reduction in tumor cells in peripheral blood (Figure S4, S5, S6).
To evaluate models of tumor clonality predicted from unfrac-
tionated samples, we overlaid tracks of single-cell variant calls on
the cluster definitions derived previously (Figure 4, Figure S7).
In general, single-cell mutation profiles strongly supported the
existence and composition of the predicted clonal populations. We
observed multiple cells from each subject harboring the majority of
targeted SNVs, and at least one cell in each subject in which
complete clusters of putatively subclonal variants were called
reference. Single-cell sequencing thus demonstrated the existence
of distinct cells arising at successive points in tumor evolution, in
addition to validating our hypothesis that SNVs present at similar
VAFs travel together in individual cells.
As shown in Figure 4, we observed a significant rate of
reference calls (15%, on average) in each cell at sites predicted to
be within a mutation cluster. Formally, this could reflect cryptic
subclonal heterogeneity, but these positions could not be
aggregated into clusters of more than a few variants. Furthermore,
mutually exclusive sets of variants that were reference in cells
representing the founding clone were recovered in cells corre-
sponding to more mature clones, which would imply an unlikely
rate of convergent evolution. Alternatively, these reference calls
likely represent stochastic false negatives in each cell. Indeed, the
rate of these reference calls was consistent with our estimated FNR
(due to ADO) of 0.12. Accordingly, the majority of these reference
calls likely reflect ADO (are false negatives), not cryptic population
substructure.
While the single-cell genotypes we obtained generally validated
our predicted model, they suggested a number of modifications.
First, there was ambiguity in our original analysis as to which clone
gave rise to cluster 5 variants in UPN461282; this appeared to be a
rare subclone that could have emerged from any of its
predecessors. The single-cell data unambiguously show that
cluster 5 SNVs descended linearly from cluster 4 (i.e., cluster 5
variants always colocalized with cluster 4 variants). Second,
approximately 9% of targeted SNVs could not be clustered in
our original study, i.e., the clone to which they belonged was
ambiguous. For UPN461282 and UPN288033 (for which we had
multiple cells representing each clone), we were able to confidently
assign 50% of these outliers to specific clones (Figure 4A, C). For
UPN182896 (for which we only had one cell representing the
founding clone), we were only able to recover 35% of outliers
(Figure 4B).
In addition to resolving the clonality of ambiguous clusters and
outliers, the single-cell data identified a small set of variants
that were mutually exclusive across multiple cells in each
subject—suggesting that a subset of targeted SNVs may in fact
represent subclones within the cluster to which they were
originally assigned (Figure 4). For UPN461282, this occurred
among low-frequency cluster 5 variants. Only 20 of the 60 variants
we targeted in this cluster were detectable—suggesting that these
variants were enriched for false positives or belonged to additional
rare subclones not sequenced in the current study—but these 20
appear to be split between two distinct clones. We observed similar
evidence of mutually exclusive variant sets (i.e., evolutionary
branch points) among the outliers that could be re-clustered in
UPN182896 and UPN288033. Again, these potential subclones
were small, consisting of only 4–5 SNVs, thus supporting the
interpretation that the dominant evolutionary relationship among
targeted variants was linear, though a minority of variants may
have arisen secondarily to major clonal expansion events.
Finally, we performed phylogenetic analysis to assess tumor
clonality based solely on the genetic distance between individual
cells (independent of predicted cluster definitions). We used
maximum likelihood to reconstruct the phylogenetic tree of each
tumor using single-cell genotypes at targeted SNVs (Figure 5),
which again supported our original model. The major clones
ascertained from single-cell mutation profiles were separated by
stable branches in each tree. These trees illustrate a generally
linear topology, in addition to the branching event within cluster 5
in UPN461282, but they also provide evidence for additional
branching events within UPN182896 and UPN288033. We
integrated single-cell mutation profiles and trees to assign groups
of individual cells to clones; we then compared the frequency of
each clone among single cells to our prediction from sequencing
unfractionated material, based on the mean VAF of each cluster,
and we found a modest but significant correlation (R2= 0.60)
(Figure S8).
Discussion
Deep sequencing of unfractionated tumors is a powerful tool for
interrogating inter- and intra-tumoral genetic variation [23].
Multiple studies have demonstrated that clonal heterogeneity is a
key aspect of cancer biology [13,15]. These results have validated
long-standing models of cancer as an evolutionary process [24],
which has clinical implications for the design of effective therapies
(selecting targeted agents and predicting response). Indeed, recent
work has demonstrated functional heterogeneity among AML
subclones [10] as well as prognostic value in detecting subclonal
variation in MDS and chronic lymphoid leukemia [25,26]. Thus,
even though the clonal architecture of individual tumors is often
strongly implied from sequencing unfractionated samples, a direct
assessment of these models and their underlying assumptions is
critical.
Here, single-cell analysis of MDS-derived secondary AML
samples generally validated predictions from prior analysis of
unfractionated samples. The vast majority of SNVs predicted to
co-occur in a clonal population were shown to be present in at
least one cell, clusters of variants corresponding to subclones were
called reference en bloc (supporting the predicted evolutionary
progression), and the frequency of each clone was correlated
(albeit, modestly) with the mean VAF of clusters in unfractionated
samples. Nevertheless, the single-cell data suggested specific
modifications to the original models. A limited set of variants
(n = 3) appear to have been misclustered in the original analysis,
35–50% of outliers could be assigned to clones for the first time,
and the ambiguous clonal assignment of clone 5 in UPN461282
was resolved. In addition, approximately 9% of targeted positions
(covered in at least one cell) were never called as variants,
Leukemia Single-Cell Sequencing
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Figure 3. Model of tumor clonality predicted from unfractionated samples. SciClone analysis and cluster assignment of previously validated
somatic mutations present in unsorted MDS and sAML bone marrow cells [14,21]. Variant allele fractions of variants at MDS (x-axis) and sAML (y-axis)
predict specific tumor substructure and evolution over time. Color-coded mutation clusters are completely non-overlapping between subjects. (A) At
sAML diagnosis, UPN461282 was predicted to harbor 10% non-tumor cells in addition to 5 subclones: 1) 6% of cells harboring cluster 1 variants (clone
1), 2) 4% of cells harboring cluster 1 and cluster 2 variants (clone 2), 3) 33% of cells harboring cluster 1, cluster 2, and cluster 3 variants (clone 3), 4)
Leukemia Single-Cell Sequencing
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suggesting that some targeted SNVs were false positives in the
original study, or belonged to subclones that were not sampled in
this study by chance.
Although most of the variants we targeted were found to
colocalize in at least one cell (supporting generally linear
evolution), we did observe clusters of variants in each subject that
were mutually exclusive (suggesting subclonal branch points).
These clusters were typically small (with five or so variants
differentiating a putative subclone), but were supported by
multiple cells. The strongest evidence for this occurred in a low-
frequency subclone in subject UPN461282 (cluster 5 variants). As
a class, it is plausible that low-frequency variants may be enriched
for complexity, i.e., may tend to be divided among multiple clones,
and/or derive from different ancestral populations. Thus, we find
that genotyping unfractionated and single-cell libraries are
complementary approaches to resolving subclonal complexity.
Analysis of unfractionated samples at multiple time points
identifies major branches that may not be appreciated at a single
33% of cells harboring cluster 1, cluster 2, cluster 3, and cluster 4 variants (clone 4), and 5) 14% of cells harboring either cluster 1, cluster 2, cluster 3,
and cluster 5 variants or cluster 1, cluster 2, cluster 3, cluster 4, and cluster 5 variants (clone 5). (B) At diagnosis with sAML, UPN182896 was predicted
to harbor 35% non-tumor cells in addition to 2 subclones: 1) 13% of cells harboring cluster 1 variants (clone 1), and 2) 52% of cells harboring cluster 1
and cluster 2 variants (clone 2). (C) At diagnosis with sAML, UPN288033 was predicted to harbor 7% non-tumor cells in addition to 2 subclones: 1)
62% of cells harboring cluster 1 variants (clone 1), and 2) 31% of cells harboring cluster 1 and cluster 2 variants (clone 2). (D) Schematic summarizing
our initial models of clonal evolution inferred from SciClone analysis—the question mark denotes ambiguity of clone 5 origin in UPN461282.
doi:10.1371/journal.pgen.1004462.g003
Figure 4. Single-cell mutation profiles. Variant profiles across targeted somatic mutations in single-cell samples (sAML bone marrow) in (A)
UPN461282, (B) UPN182896, and (C) UPN288033. Rows display positive and negative variant calls color-coded by mutation cluster for each single-cell
sample, and columns indicate specific SNVs somatic at sAML diagnosis. Variants are grouped and color-coded by cluster as predicted from
sequencing unfractionated material (uppermost track in each panel). Each cell is grouped by the clone it is inferred to represent. Outlier SNVs (purple)
were those which could not be confidently clustered based on bulk sequencing. Here, many of these are merged into predicted clusters based upon
their presence/absence in single-cell libraries (i.e., harboring the same pattern as well-defined clones). Positions where reference calls were made are
colored grey; positions where no call was made (,256coverage) are colored white. Pairs of variants that always travel in the same state (reference or
variant) likely arose in the same clonal expansion. Pairs of variants that are called together in some cells but not others are likely related by linear
evolution. Pairs of variants that are mutually exclusive suggest evolutionary branch points, and were rare. This suggested that variants in subclone 5
in UPN461282 (A), and subclone 1 in UPN288033 (C) were divided among additional subclones (now 5A/5B, 2A/2B). See Figure S7 for data
presentation with unmodified clone and cluster definitions (derived from bulk sequencing).
doi:10.1371/journal.pgen.1004462.g004
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time point (e.g., clone 1.clone 2.clone 3 in UPN461282),
whereas single-cell genotyping improves the interpretation of low-
frequency variants (removing false positive calls and revealing
cryptic clonal substructure).
Consistent with our results, recent work by Klco et al. has
shown that single-cell genotyping supports the tumor clonality
predicted from unfractionated de novo AML samples [10]. Klco et
al. used WGA and amplicon sequencing to assay a smaller
number of clonal markers (n = 1–3 SNVs per clone, 10 total)
across a larger number of single cells (n = 95). This illustrated the
utility of a large sample size for accurately estimating clone
frequencies from single cells—Klco et al. achieved more precise
single-cell estimates of variant frequencies that more closely
matched estimates from bulk tumors. Alternatively, our analysis of
several hundred clonal markers suggested that the secondary AML
tumors we analyzed harbored complexity that was not appreciated
Figure 5. Single-cell reconstruction of tumor phylogeny. Maximum likelihood phylogenetic trees derived from single-cell genotypes at
targeted somatic SNVs. (A) UPN461282 (B) UPN182896 (C) UPN288033. Values along edges represent branch support determined by non-parametric
bootstrap (n = 1000 iterations). Edges with $75% support are considered strongly supported. Cell labels are identical to those in Figure 4, and
colored based on the presence variant clusters corresponding to the profiles detailed in Figure 4.
doi:10.1371/journal.pgen.1004462.g005
Leukemia Single-Cell Sequencing
PLOS Genetics | www.plosgenetics.org 8 July 2014 | Volume 10 | Issue 7 | e1004462
by bulk analysis, and assaying a small number of variants per clone
would not have shown this. Together, the Klco et al. study and our
own suggest that the clonal architecture of complex tumors is best
appreciated through the analysis of a large number of variants
across a large number of cells.
Previous reports of single-cell sequencing have already de-
scribed the primary technical challenges we encountered in this
study: 1) locus dropout and non-uniform coverage led to a
substantial amount of missing data (positions inadequately
covered), and 2) ADO compromised the accuracy of variant
calling at heterozygous sites [10–12,16,27,28]. Nevertheless,
previous studies have generally attempted variant discovery from
single-cell sequencing, whereas we sought to genotype a defined
set of validated variants, i.e., to understand the clonal relationships
among SNVs that were supported by prior knowledge. Alterna-
tively, others have reported analyses of tumor clonality using more
accurate single-cell genotyping methods (FISH, allele-specific
PCR) [7–9], but these lack the throughput required to assay
hundreds of variants simultaneously. Therefore, as improvements
to WGA technologies are developed (increasing coverage and
reducing allelic bias) [16], in addition to more sensitive methods
for rare variant detection [29,30], a capture-based strategy offers
an attractive balance of throughput and cost-effectiveness for
studying tumor clonality. Accordingly, the approach we have
outlined here—integrating both variant discovery in bulk samples,
and clonality analysis in single-cells—could be used to confidently
localize mutations within clonal hierarchies prior to the initiation
of targeted therapies. This has the potential to inform treatment
regimens that target complex populations of cells, not just isolated
subclones, which may lead to improved patient outcomes.
Materials and Methods
Subjects and Samples
All subjects were diagnosed with de novo myelodysplastic
syndrome (MDS) and progressed to secondary acute myeloid
leukemia (sAML) within 32 months. UPN461282: 65 year-old
male (refractory anemia with excess blasts and complex karyo-
type); UPN182896: 75 year-old male (refractory anemia with
trisomy 8); UPN288033: 31 year-old female (refractory anemia
with excess blasts and normal karyotype). Detailed clinical histories
have been reported previously [14]. All subjects provided written
informed consent authorizing whole genome sequencing on a
protocol approved by the Washington University Office of Human
Research Protection.
SNP Genotyping and Somatic Mutation Discovery in
Unfractionated Samples
Affymetrix 6.0 SNP genotyping and WGS of unfractionated
normal, MDS, and secondary AML samples were performed as
described previously [14]. Somatic mutations were validated by
solid phase targeted capture and deep sequencing.
Isolation and Amplification of Single-Cell DNA
Single vials of cryopreserved bone marrow cells from each
subject at sAML diagnosis were thawed, washed in PBS, counted,
and adjusted to 7.5 million cells/mL. Single bone marrow cells
were deposited into 96 well plates by flow cytometric cell sorting.
Additional microtiter plates with two-cells per well were generated
to produce intentionally ‘‘cross-contaminated’’ samples. Bivariate
plot isolation of single, viable cells was made by forward low angle
light scatter and 90 degree light scatter against apex debris and
noise, as well as scatter pulse width to isolate single cells from
aggregates. This sort decision was applied to a MoFlo cell sorter
(Beckman Coulter Inc., Brea, CA) equipped with a Cyclone X-Y
deposition instrument, configured to deposit densities of 0–4 cells
per well. The coincident cell abort mask was set to be the most
stringent, allowing sorted droplets to contain only one target cell
with no particles within adjacent droplets.
Cells were sorted directly into extraction buffer; genomic DNA
extraction and amplification were carried out using a PicoPlex
WGA kit according to the manufacturer’s protocol (Rubicon
Genomics, Ann Arbor, MI). WGA DNA yield was determined by
Qubit fluorometric quantitation (Life Technologies, Carlsbad,
CA), and WGA DNA quality was assessed by qPCR.
Sequencing Library Production and Target Enrichment
Sequencing libraries were prepared from single-cell WGA DNA
(n= 12 per subject), two-cell WGA DNA (two cells intentionally
deposited in one well, n = 2 per subject), as well as unamplified
genomic DNA from unsorted samples—bone marrow and
peripheral blood cells (at MDS and sAML diagnosis) and matched
normal tissue (skin biopsy) (Table S1). Barcoded paired-end
Illumina libraries were prepared according to the manufacturer’s
recommendations (Illumina Inc., San Diego, CA), with the
following exceptions: 1) 250–1000 ng of WGA DNA (sorted
samples) and 1000–3000 ng of unamplified DNA (unsorted
samples) were fragmented using the Covaris E220DNA Sonicator
(Covaris Inc., Woburn, MA) to a size range between 100–400 bp;
2) Illumina adapter-ligated library fragments were amplified in
four 50 mL PCR reactions for eighteen cycles; 3) Solid Phase
Reversible Immobilization (SPRI) bead cleanup was used for
enzymatic purification throughout the library process, as well as
final library size selection targeting 300–500 bp fragments.
All 56 sequencing libraries were pooled (normalized to 85 ng
per library) and hybridized in solution to a custom library of
capture oligonucleotides targeting 492,297 bases, according to the
manufacturer’s protocol (Roche NimbleGen, Madison, WI).
Capture baits targeted a total of 1,953 validated somatic single
nucleotide variants (SNVs): 872 SNVs from UPN461282, 777
SNVs from UPN182896, and 304 SNVs from UPN288033, as
reported previously [14] (Table S2). qPCR was used to calibrate
flow cell loading concentration and cluster density. Libraries were
run on a single lane of an Illumina HiSeq2000, according the
manufacturer’s recommendations (Illumina Inc., San Diego, CA).
Bioinformatics Analysis
Illumina reads were de-multiplexed and aligned to the NCBI
37/hg19 reference sequence (GRCh37-lite) using BowTie2 in
local mode to allow soft-clipping of WGA adapter sequences [31].
Binary alignment/map (BAM) files were merged and duplicates
marked using Picard v1.46 (http://picard.sourceforge.net). Cov-
erage metrics were calculated with GATK v1.2 DepthOfCover-
age, with reads filtered for a minimum alignment score of 10 (-
mmq10) and a minimum base quality of 13 (-mbq13) [19,20].
Read pileups were generated for individual samples with the
SAMtools v0.1.18 mpileup command using default settings with
the following exceptions: 1) base alignment quality (BAQ)
computation disabled (-B); 2) minimum alignment score of 10 (-
q 10); and 3) minimum base quality score of 13 (-Q 13); 4)
maximum read depth of 99999 (-d 99999) [17]. Variants were
called from individual sample pileup files with either SAMtools or
VarScan v2.3.5 using default parameters [17,18], or using the
GATK Unified Genotyper applied jointly across all single-cell
libraries [19,20]. The identity of each sample was confirmed by
variant calls at known germline homozygous SNPs (Table S4), as
well as individual-specific somatic SNVs (Table S5).
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Phylogenetic Analysis
Phylogenetic analysis was performed in R (v3.0.1) using the
packages ape [32] and phangorn [33]. Briefly, genetic distances
were estimated among all single cells for each subject under a
generalized Kimura model [34], and initial trees were derived
using a modified neighbor joining algorithm. Likelihood optimi-
zation was then used to obtain the maximum likelihood (ML) tree
for each subject using a generalized time reversible (GTR)
substitution model. Finally, we performed a non-parametric
bootstrap on each ML tree to estimate the support for individual
branches (n = 1000 iterations).
Maximum Likelihood Estimation of Sample Cellularity
For each single- and two-cell sample, the number of variant reads
at heterozygous loci was modeled as a binomial process with a
probability, p, derived from: 1) the variant allele fraction, f, in the
original population (putatively 1 or 2 cells), and 2) the cumulative
error rate, e, attributable to WGA, library preparation, and
sequencing. I.e., for each locus, P(X= k),Bin(n,p), where k is the
number of variant reads, n is the total read depth, and p is given by
p= f(12e)+(12f)e. For each mutation cluster, the cumulative
likelihood of the observed variant allele counts was calculated using
specific VAFs for every possible combination of two clones. A
likelihood ratio test using a one-sided chi-square distribution with 1
degree of freedom was then applied to calculate the overall
probability that the observed variant allele fraction distribution was
generated from a clonally pure (single-cell) or clonally heteroge-
neous (two-cell) sample. For each subject, the cumulative error rate
was estimated for each cluster by calculating the mean VAF at these
sites among single-cell samples from the other two subjects (samples
expected to be reference at these positions). I.e., since all samples
were processed in parallel and run on the same sequencing lane,
subjects served as mutual controls for modeling the site-specific
error rates intrinsic to WGA, library prep, and sequencing.
Supporting Information
Figure S1 Correlation of VAFs between array-based and liquid-
phase targeted sequencing. Libraries prepared from genomic
DNA (without amplification) from unfractionated MDS (left
panels) or sAML (right panels) bone marrow cells were enriched
for target regions by hybridization capture. The variant allele
fraction (VAF) for each targeted SNV determined by array-based
(x-axis, previous study [14]) and liquid-phase capture (y-axis,
current study) is plotted for each sample. The R2 is included for
each pair. The VAFs for somatic SNVs are highly correlated
between capture reagents.
(PDF)
Figure S2 Genotyping errors at germline heterozygous posi-
tions. The average number of genotype calls per library are plotted
for each individual and sample type (unfractionated, single- and
two-cell) at positions known to be germline heterozygous SNPs
(based on Affymetrix arrays). Heterozygous calls (‘‘Het’’) therefore
represent the correct genotypes at these loci, whereas homozygous
reference (‘‘Hom Ref’’) or homozygous variant calls (‘‘Hom Alt’’)
represent a genotyping error due to the loss of a single allele. These
errors are rare in unfractionated samples, and—among sorted
samples—losses of reference and variant alleles occur at roughly
equal rates (two-sided binomial exact test), supporting ADO as the
underlying mechanism. Statistical tests comparing proportion of
homozygous reference and homozygous variant errors were
omitted for UPN461282 due to an inadequate number of
genotype observations.
(PDF)
Figure S3 Pairwise comparison of dropout rates among germ-
line heterozygous positions between subjects. The false negative
rate (FNR) for each single-cell library was assessed at heterozygous
sites common to all three subjects. The R2 is included for each
pairwise comparison (A–C). There appears to be a weak
correlation between subjects, but site-specific effects only explain
25–30% of the variance in FNR. I.e., the rate of allelic dropout
appears to be predominantly driven by stochastic effects.
(PDF)
Figure S4 VAF distribution for UPN461282 predicted hetero-
zygous somatic mutations among all sequenced samples. (A)
Unfractionated samples—sAML bone marrow, MDS bone
marrow, MDS peripheral blood, and skin—demonstrate the
emergence of distinct mutation clusters over time with successively
lower mean VAFs. (B) The VAF distribution among single cells
appears uniform for each cluster, centered on 0.5—except cluster
5, which our analyses suggest was enriched for false positives and
composed of at least two mutually exclusive sub-clusters. (C) Two-
cell experiments show deviations from 0.5 in specific variants—all
three clusters in two-cell 1 (suggesting a non-clonal cell mixed with
a clone 3 cell), but only cluster 4 in two-cell 2 (consistent with a
clone 3 cell mixed with a clone 4 cell). Clone numbers denote the
latest mutation cluster observed in a particular cell; e.g. clone 2
harbors mutations from clusters 1 and 2. BM: bone marrow. PB:
peripheral blood.
(PDF)
Figure S5 VAF distribution for UPN182896 predicted hetero-
zygous somatic mutations among all sequenced samples. (A)
Unfractionated samples—sAML bone marrow, sAML peripheral
blood, MDS bone marrow, MDS peripheral blood, and skin—
demonstrate the emergence of distinct mutation clusters over time
with successively lower mean VAFs. (B) The VAF distribution
among single cells appears uniform for each cluster, centered on
0.5. Cell 12 exhibits less variance than other single cells, suggesting
this library was derived from multiple cells (it was excluded from
all single-cell analyses). (C) Two-cell experiments show no
deviations in mean VAF, suggesting two cells belonging to the
same clone were sorted in each (clone 2 cells and healthy cells were
estimated to constitute 52% and 35% of the sample, respectively).
Clone numbers denote the latest mutation cluster observed in a
particular cell; e.g. clone 2 harbors mutations from clusters 1 and
2. BM: bone marrow. PB: peripheral blood.
(PDF)
Figure S6 VAF distribution for UPN288033 predicted hetero-
zygous somatic mutations among all sequenced samples. (A)
Unfractionated samples—sAML bone marrow, sAML peripheral
blood, MDS bone marrow, MDS peripheral blood, and skin—
demonstrate the emergence of distinct mutation clusters over
time with successively lower mean VAFs. (B) The VAF
distribution among single cells appears uniform for each cluster,
centered on 0.5. (C) Two-cell experiments show deviations from
0.5 in cluster 2 variants. The mean VAF of cluster 2 in two-cell 2
is diluted near 0.25, consistent with a clone 1 cell mixed with a
clone 2 cell. The mean VAF of clusters 1 and 2 in two-cell 1 do
not appear to be 0.25 or 0.50, suggesting that more than two cells
were sequenced in this library. No non-tumor samples were
observed in single- or two-cell samples, but these were only
predicted to be present at ,7%. Here, clone numbers denote the
latest mutation cluster observed in a particular cell; e.g. clone 2
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Figure S7 Unedited variant profiles. Variant profiles across
targeted somatic mutations in single-cell samples (sAML bone
marrow) in (A) UPN461282, (B) UPN182896, and (C)
UPN288033. Rows display positive and negative variant calls
color-coded by mutation cluster for each single-cell sample, and
columns indicate specific SNVs somatic at sAML diagnosis.
Variants are grouped and color-coded by cluster as predicted from
sequencing unfractionated material (uppermost track in each
panel). Each cell is grouped by the clone it is inferred to represent.
Outlier SNVs (purple) were those which could not be confidently
clustered based on bulk sequencing. Positions where reference calls
were made are colored grey; positions where no call was made (,
256 coverage) are colored white. Pairs of variants that always
travel in the same state (reference or variant) likely arose in the
same clonal expansion. Pairs of variants that are called together in
some cells but not others are likely related by linear evolution.
Pairs of variants that are mutually exclusive suggest evolutionary
branch points, and were rare. Clone and variant assignment are
derived solely from predictions from bulk sequencing.
(TIF)
Figure S8 Correlation of clone frequencies derived from
unfractionated samples and single cells. Previous whole genome
sequencing identified 2–5 clusters within the VAF distributions for
each subject in the current study [14]. Each cluster was predicted
to correspond to a defined subclone at a frequency approximately
equal its mean VAF (x-axis). Sequencing 11–12 single-cell libraries
and 1–2 two-cell libraries for each subject yielded mutation
profiles generally consistent with predicted clones, allowing direct
determination of clone frequencies (y-axis).
(PDF)
Table S1 Summary of sample set. Summary of source material
for each of the 56 libraries sequenced in this study.
(XLSX)
Table S2 Summary of targeted SNVs. Characteristics of each
targeted SNV discovered and validated in the previous study [14].
The right-most 56 columns list the variant allele fraction (VAF) of
each variant in every sequenced sample.
(XLSX)
Table S3 Detailed sequencing metrics. Summary of sequencing
data generated, aligned, on-target and non-PCR/optical duplicate
for each sample.
(XLSX)
Table S4 Identity confirmation at germline homozygous SNPs.
Targeted regions included 26 germline homozygous SNPs
(ascertained by Affymetrix 6.0 SNP arrays) that differentiated
UPN182896 and UPN288033 (data not available for
UPN461282). Next-generation sequencing calls verified the
sample identity of unfractionated material as well as single-and
two-cell samples at these loci (overall true positive rate
(TPR) = 0.98).
(XLSX)
Table S5 Identity confirmation at somatic SNVs. For each
subject, summary of non-reference calls at positions harboring
somatic SNVs in either of the other two subjects. Somatic SNVs
were mutually exclusive between subjects, so the expected non-
reference call rate is 0, and non-reference calls constitute false
positives. These data provided additional verification that each
sample was derived from the intended subject (overall false positive
rate (FPR),0.01).
(XLSX)
Table S6 Variant calling performance at germline SNPs.
Sample-level data detailing accuracy of next-generation sequenc-
ing variant calls compared to Affymetrix array genotypes. True
positive (TP): variant allele called by NGS at a site with $1 non-
reference alleles called by Affymetrix array. True negative (TN):
reference alleles called by NGS at a site with 0 non-reference
alleles called by Affymetrix array. False positive (FP): variant allele
called by NGS at a site with 0 non-reference alleles called by
Affymetrix array. False negative (FN): reference allele called by
NGS at a site with $1 non-reference alleles called by Affymetrix
array. True positive rate (TPR): TP/(TP+FN)= sensitivity =
power. False positive rate (FPR) =FP/(FP+TN) = 1 – specificity.
False negative rate (FNR) =FN/(FN+TP)= 1- sensitivity.
(XLSX)
Table S7 Maximum likelihood analysis. Summary of maximum
likelihood analysis of VAF distributions for each single- and 2-cell/
well sample. For .90% of single-cell samples, MLE predicts the
observed VAFs were derived from a clonally pure sample. The
model does not differentiate between 1 cell and 2 cells of the same
clone type. It is unlikely that multiple cells were sorted and in 35/
36 cases contained only one clone type. Five putative single-cell
samples were predicted to be heterogeneous (i.e., they represent
the admixture of at least two distinct clones). Four of these involve
UPN461282 cluster 5, which 1) appear to have been enriched for
false positives, and 2) appear to have been split between at least
two independent subclones. The fifth (UPN182896 single-cell 12)
appears to be a genuine sorting error, and data from this cell were
excluded from all single-cell analyses. Two putative 2-cell/well
samples were predicted to be homogenous, which may reflect
sorting two cells of the same type (this tumor was largely clone 2
and wild type), or the failure to successfully sort a second cell.
MLE Predicted State: most likely two-cell configuration. Expected
Clone: state assuming sample was single-cell, belonging to a clone
defined by the latest cluster with variant alleles detected. LRT: p-
value from one-sided chi-square distribution with one degree of
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